Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Alzheimer's disease | R-HSA-1643685 | 0 | vanoxerine | 9999342 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | vanoxerine | 9999342 | drug-path |
Nucleotide excision repair | R-HSA-5696398 | map03420 | vanoxerine | 9999342 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | vanoxerine | 9999342 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | vanoxerine | 9999342 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | vanoxerine | 9999342 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | vanoxerine | 9999342 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | vanoxerine | 9999342 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | vanoxerine | 9999342 | drug-path |
Vibrio cholerae infection | R-HSA-9609646 | map05110 | vanoxerine | 9999342 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | vanoxerine | 9999342 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | vanoxerine | 9999342 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | vanoxerine | 9999342 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | vanoxerine | 9999342 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ouabain | 439501 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ouabain | 439501 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ouabain | 439501 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | ouabain | 439501 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | ouabain | 439501 | drug-path |
Gap junction | R-HSA-190861 | map04540 | ouabain | 439501 | drug-path |